Tuesday, May 04, 2021 9:21:13 PM
Hi sentiment sorry the late reply here. I'm sharing the link to Linda Liaus grand round presentation in 2019... The same one that is scheduled for June 3rd (which as an aside is in my opinion an even further confirmation we will have TLD on or prior to that date).
I'm not sure if anyone or everyone has seen this presentation already but it is probably the most honest, in depth reviews of the end to end phase 1-3 DCVax trial. As I was watching this, I've realized that I am not sure what we are all expecting to be surprised about in terms of TLD, all of the data about the trial is thoroughly discussed in this presentation. While in rewatching this presentation today, I've learned a lot of new information and took a lot of notes which I will share with ya'll here soon along with the reference time stamp. Following biosect's post regarding all of the chaos that went on during the duration of the trial (recession, changes in radiology, changes in tumor understanding, etc) it is a pretty incredible feat how the company kept the needle moving forward and positioned us where we are today. You really have to watch and pay close attention to appreciate.
That said, getting back to my original reasoning for this post, senti, Linda clearly states that verbatim, "we still have 75% of people who don't live past 3 years."
I'm not sure if anyone or everyone has seen this presentation already but it is probably the most honest, in depth reviews of the end to end phase 1-3 DCVax trial. As I was watching this, I've realized that I am not sure what we are all expecting to be surprised about in terms of TLD, all of the data about the trial is thoroughly discussed in this presentation. While in rewatching this presentation today, I've learned a lot of new information and took a lot of notes which I will share with ya'll here soon along with the reference time stamp. Following biosect's post regarding all of the chaos that went on during the duration of the trial (recession, changes in radiology, changes in tumor understanding, etc) it is a pretty incredible feat how the company kept the needle moving forward and positioned us where we are today. You really have to watch and pay close attention to appreciate.
That said, getting back to my original reasoning for this post, senti, Linda clearly states that verbatim, "we still have 75% of people who don't live past 3 years."
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
